Cargando…
Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population
Whether SARS-CoV-2 infection and COVID-19 vaccines confer exposure-dependent (“leaky”) protection against infection remains unknown. We examined the effect of prior infection, vaccination, and hybrid immunity on infection risk among residents of Connecticut correctional facilities during periods of...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439918/ https://www.ncbi.nlm.nih.gov/pubmed/37598213 http://dx.doi.org/10.1038/s41467-023-40750-8 |
_version_ | 1785093057814724608 |
---|---|
author | Lind, Margaret L. Dorion, Murilo Houde, Amy J. Lansing, Mary Lapidus, Sarah Thomas, Russell Yildirim, Inci Omer, Saad B. Schulz, Wade L. Andrews, Jason R. Hitchings, Matt D. T. Kennedy, Byron S. Richeson, Robert P. Cummings, Derek A. T. Ko, Albert I. |
author_facet | Lind, Margaret L. Dorion, Murilo Houde, Amy J. Lansing, Mary Lapidus, Sarah Thomas, Russell Yildirim, Inci Omer, Saad B. Schulz, Wade L. Andrews, Jason R. Hitchings, Matt D. T. Kennedy, Byron S. Richeson, Robert P. Cummings, Derek A. T. Ko, Albert I. |
author_sort | Lind, Margaret L. |
collection | PubMed |
description | Whether SARS-CoV-2 infection and COVID-19 vaccines confer exposure-dependent (“leaky”) protection against infection remains unknown. We examined the effect of prior infection, vaccination, and hybrid immunity on infection risk among residents of Connecticut correctional facilities during periods of predominant Omicron and Delta transmission. Residents with cell, cellblock, and no documented exposure to SARS-CoV-2 infected residents were matched by facility and date. During the Omicron period, prior infection, vaccination, and hybrid immunity reduced the infection risk of residents without a documented exposure (HR: 0.36 [0.25–0.54]; 0.57 [0.42–0.78]; 0.24 [0.15–0.39]; respectively) and with cellblock exposures (0.61 [0.49–0.75]; 0.69 [0.58–0.83]; 0.41 [0.31–0.55]; respectively) but not with cell exposures (0.89 [0.58–1.35]; 0.96 [0.64–1.46]; 0.80 [0.46–1.39]; respectively). Associations were similar during the Delta period and when analyses were restricted to tested residents. Although associations may not have been thoroughly adjusted due to dataset limitations, the findings suggest that prior infection and vaccination may be leaky, highlighting the potential benefits of pairing vaccination with non-pharmaceutical interventions in crowded settings. |
format | Online Article Text |
id | pubmed-10439918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-104399182023-08-21 Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population Lind, Margaret L. Dorion, Murilo Houde, Amy J. Lansing, Mary Lapidus, Sarah Thomas, Russell Yildirim, Inci Omer, Saad B. Schulz, Wade L. Andrews, Jason R. Hitchings, Matt D. T. Kennedy, Byron S. Richeson, Robert P. Cummings, Derek A. T. Ko, Albert I. Nat Commun Article Whether SARS-CoV-2 infection and COVID-19 vaccines confer exposure-dependent (“leaky”) protection against infection remains unknown. We examined the effect of prior infection, vaccination, and hybrid immunity on infection risk among residents of Connecticut correctional facilities during periods of predominant Omicron and Delta transmission. Residents with cell, cellblock, and no documented exposure to SARS-CoV-2 infected residents were matched by facility and date. During the Omicron period, prior infection, vaccination, and hybrid immunity reduced the infection risk of residents without a documented exposure (HR: 0.36 [0.25–0.54]; 0.57 [0.42–0.78]; 0.24 [0.15–0.39]; respectively) and with cellblock exposures (0.61 [0.49–0.75]; 0.69 [0.58–0.83]; 0.41 [0.31–0.55]; respectively) but not with cell exposures (0.89 [0.58–1.35]; 0.96 [0.64–1.46]; 0.80 [0.46–1.39]; respectively). Associations were similar during the Delta period and when analyses were restricted to tested residents. Although associations may not have been thoroughly adjusted due to dataset limitations, the findings suggest that prior infection and vaccination may be leaky, highlighting the potential benefits of pairing vaccination with non-pharmaceutical interventions in crowded settings. Nature Publishing Group UK 2023-08-19 /pmc/articles/PMC10439918/ /pubmed/37598213 http://dx.doi.org/10.1038/s41467-023-40750-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Lind, Margaret L. Dorion, Murilo Houde, Amy J. Lansing, Mary Lapidus, Sarah Thomas, Russell Yildirim, Inci Omer, Saad B. Schulz, Wade L. Andrews, Jason R. Hitchings, Matt D. T. Kennedy, Byron S. Richeson, Robert P. Cummings, Derek A. T. Ko, Albert I. Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population |
title | Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population |
title_full | Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population |
title_fullStr | Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population |
title_full_unstemmed | Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population |
title_short | Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population |
title_sort | evidence of leaky protection following covid-19 vaccination and sars-cov-2 infection in an incarcerated population |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439918/ https://www.ncbi.nlm.nih.gov/pubmed/37598213 http://dx.doi.org/10.1038/s41467-023-40750-8 |
work_keys_str_mv | AT lindmargaretl evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT dorionmurilo evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT houdeamyj evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT lansingmary evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT lapidussarah evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT thomasrussell evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT yildiriminci evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT omersaadb evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT schulzwadel evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT andrewsjasonr evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT hitchingsmattdt evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT kennedybyrons evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT richesonrobertp evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT cummingsderekat evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation AT koalberti evidenceofleakyprotectionfollowingcovid19vaccinationandsarscov2infectioninanincarceratedpopulation |